We sat down with Declan Soden, CEO at Mirai Medical, who shared how pulsed electric field technology is transforming GI cancer treatment with zero adverse events in 100 patients.
He shares details about efficiently raising €30M, building the right team, navigating oncology adoption barriers, and scaling from CE Mark to FDA approval. Learn about one of the most exciting MedTechs leading the way in precision medicine in this deep dive into non-thermal ablation innovation.
🔗 Learn more about Mirai Medical
🎧 Listen on Spotify